EGFR and lung cancer: Recent NGS studies have shown that EGFR mutations and co-mutations appear to influence the prognosis of advanced EGFR-mutated lung cancers [12,13,14]; however, there have been only a few targeted NGS analysis studies regarding the prognosis of resected early stage EGFR-mutated lung cancer that focused on recurrence [15,16,17].